To investigate whether PARP3 plays a role in the PI3K/AKT/mTOR signaling pathway in AML, we examined the expression and phosphorylation status of key molecules in this pathway after PARP3 knockdown. This evidence concerns the gene AKT1 and acute myeloid leukemia.